As temperatures rise, so does the risk of heat-related illness—especially for people taking certain prescription drugs.

“It’s kind of a sexy term” for a drug that rarely includes actual coke, says one researcher, but that hasn’t hurt the popularity of pink cocaine.

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Betaine, a compound that becomes more abundant in men who take up jogging, could confer some of the anti-ageing advantages of physical activity.

Trump’s most-favored-nation executive order would collapse the American pharmaceutical industry’s innovation edge.

Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, as the company plans to adjust dosing.

Obesity drugs show promise for treating a new ailment: migraine Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

Ecuador’s most wanted man and leader of the Los Choneros gang, Jose Adolfo Macias, was captured on Wednesday, according to the country’s President Daniel Noboa.

USC's new AI implant promises drug-free relief for chronic pain USC researchers have developed a groundbreaking ultrasound device that could reduce our reliance on addictive painkillers.

A combination featuring Exelixis’ experimental drug zanzalintinib has beaten Bayer’s gastrointestinal cancer med Stivarga in a phase 3 trial.

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.